Top Ten most popular articles on Pharmafile.com this week
September 25, 2020Medical Communications
The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have …
Novartis’ Zolgensma hits regulatory hurdle after FDA asks to review another study
September 24, 2020Research and Development FDA
The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for …
COVID-19 track and trace app launched in England and Wales after months of delays
September 24, 2020Medical Communications, Sales and Marketing UK, VOCID-19, app, test and trace
The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …
FDA grants Emergency Use Authorization for first antibody point-of-care COVID-19 test
September 24, 2020Research and Development
The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus. This is …
‘Smart drugs’ may contain unapproved pharmaceuticals, according to a new study
September 24, 2020Sales and Marketing FDA, regulation, smart drugs
Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new …
Gilead agrees to pay $97 million to settle Medicare kickbacks case
September 24, 2020Business Services Gilead, Medicare, drugs, kickbacks
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …
Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial
September 23, 2020Research and Development AstraZeneca, COVID-19, Vaccine
The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …
Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients
September 23, 2020Research and Development, Sales and Marketing
Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …
FDA set to announce stricter criteria for COVID-19 vaccines to receive Emergency Use Authorization
September 23, 2020Research and Development
The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine …
Contracting flu and COVID-19 simultaneously increases the risk of death, new study shows
September 23, 2020Research and Development coronavirus vaccine, flu vaccine, vaccines
Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …
Pharmafile.com’s weekly COVID-19 news round-up
September 23, 2020Research and Development COVID-19, coronavirus
The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …
AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal
September 22, 2020Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma
AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …
Clinical trials for Russia’s Sputnik-V vaccine in India could start in the coming weeks
September 22, 2020Manufacturing and Production Russia Vaccine, vaccines
Clinical trials testing Russia’s Sputnik-V coronavirus vaccine in India could begin in the next few weeks, according to Indian pharma …
CDC says its updated guidance stating coronavirus spreads through the air was posted in “error”
September 22, 2020Manufacturing and Production CDC, COVID-19
The US Centers for Disease Control and Prevention (CDC) has removed its guidance that said coronavirus was transmitted through the …
Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer
September 22, 2020Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma
MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus
September 22, 2020Manufacturing and Production OxyContin, Purdue, Purdue Pharma
Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …
New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020
September 21, 2020Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda
New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer
September 21, 2020Sales and Marketing AstraZeneca
AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …
Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency
September 21, 2020Sales and Marketing thyroid, thyroid drugs
Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …
Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020
September 21, 2020Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma
New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
